Novo Nordisk A/S

NVO·NYSE·Healthcare
Compare
42.18+1.99 (+4.95%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market41.50−0.67 (−1.60%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close40.19
Open42.45
Day range42.1243.24
52-week range35.1264.16
Off day high−2.45%
Off 52-week high−34.26%
Volume25.57M
Avg. volume (3M)12.18M
Market cap185.98B
EPS (TTM)3.96
Forward P/E12.26
P/E ratio (TTM)10.65
Dividend yield4.26% (1.80)
Beta (5Y)0.37
Shares outstanding3.33B
Short interest1.18% of float
Earnings dateNov 4, 2026 (est.)
Analyst target45.35
Profit margin35.35%

Against its peers

Compare in full ›
NVO 0QYQ.IL NVS LLY BIIB.MX 0NZU.IL
Market cap 185.98B 219.86B 311.59B 1.26T 693.22B 14.42B
P/E (TTM) 10.7 40.6 31.5 46.0 115.0 —
Forward P/E 12.3 — 16.6 28.3 — —
Price/book 5.7 10.4 8.4 31.4 2.0 8.2
Dividend yield 4.26% 3.81% 2.87% 0.49% — —
1-year change −9.31% +40.64% +30.35% +51.26% +68.09% −43.38%
Today +4.95% +2.59% +3.59% +0.61% 0.00% +1.45%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Latest news

All NVO news ›
Central Oregon Daily·Positive

Novo hikes outlook again as it speeds up Wegovy pill rollout

The logo of pharmaceutical company Novo is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, November 3, 2026. REUTERS/Tom Little A blister pack containing Wegovy (semaglutide) tablets on a line in Novo Nordisk’s…

From the 4Search news index, newest first.

In the news

296mentions in 30 days
176with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance